These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31671446)

  • 21. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.
    Wkly Epidemiol Rec; 2010 Feb; 85(8):47-63. PubMed ID: 20210043
    [No Abstract]   [Full Text] [Related]  

  • 22. Infectious disease. Hitting early, epidemic meningitis ravages Nigeria and Niger.
    Roberts L
    Science; 2009 Apr; 324(5923):20-1. PubMed ID: 19342555
    [No Abstract]   [Full Text] [Related]  

  • 23. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
    Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
    Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009.
    Bassey BE; Vaz RG; Gasasira AN; Braka F; Weldegriebriel G; Komakech W; Toritseju MS; Fatiregun AA; Okocha-Ejeko A
    Int J Infect Dis; 2016 Feb; 43():62-67. PubMed ID: 26724773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
    PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The meningitis outbreak returns to Niger: Concern, efforts, challenges, and recommendations.
    Sibomana O; Hakayuwa CM
    Immun Inflamm Dis; 2023 Jul; 11(7):e953. PubMed ID: 37506148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.
    Trotter CL; Lingani C; Fernandez K; Cooper LV; Bita A; Tevi-Benissan C; Ronveaux O; Préziosi MP; Stuart JM
    Lancet Infect Dis; 2017 Aug; 17(8):867-872. PubMed ID: 28545721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.
    Kretz CB; Retchless AC; Sidikou F; Issaka B; Ousmane S; Schwartz S; Tate AH; Pana A; Njanpop-Lafourcade BM; Nzeyimana I; Nse RO; Deghmane AE; Hong E; Brynildsrud OB; Novak RT; Meyer SA; Oukem-Boyer OOM; Ronveaux O; Caugant DA; Taha MK; Wang X;
    Emerg Infect Dis; 2016 Oct; 22(10):1762-1768. PubMed ID: 27649262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.
    Sidikou F; Potts CC; Zaneidou M; Mbaeyi S; Kadadé G; Paye MF; Ousmane S; Issaka B; Chen A; Chang HY; Issifou D; Lingani C; Sakande S; Bienvenu B; Mahamane AE; Diallo AO; Moussa A; Seidou I; Abdou M; Sidiki A; Garba O; Haladou S; Testa J; Obama Nse R; Mainassara HB; Wang X
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S206-S215. PubMed ID: 31671439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak news. Meningococcal disease, African meningitis belt.
    Wkly Epidemiol Rec; 2009 Apr; 84(15):117-8. PubMed ID: 19360984
    [No Abstract]   [Full Text] [Related]  

  • 34. An Update on Meningococcal Vaccination.
    Garland JM
    R I Med J (2013); 2020 Aug; 103(6):41-43. PubMed ID: 32752565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation.
    Wkly Epidemiol Rec; 2017 Oct; 92(41):612-7. PubMed ID: 29028166
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.
    Kwambana-Adams BA; Amaza RC; Okoi C; Rabiu M; Worwui A; Foster-Nyarko E; Ebruke B; Sesay AK; Senghore M; Umar AS; Usman R; Atiku A; Abdullahi G; Buhari Y; Sani R; Bako HU; Abdullahi B; Yarima AI; Sikiru B; Moses AO; Popoola MO; Ekeng E; Olayinka A; Mba N; Kankia A; Mamadu IN; Okudo I; Stephen M; Ronveaux O; Busuttil J; Mwenda JM; Abdulaziz M; Gummi SA; Adedeji A; Bita A; Omar L; Djingarey MH; Alemu W; D'Alessandro U; Ihekweazu C; Antonio M
    Sci Rep; 2018 Sep; 8(1):14194. PubMed ID: 30242204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine shortage threatens spread of meningitis in Niger.
    Maurice J
    Lancet; 2015 Jun; 385(9984):2241. PubMed ID: 26088485
    [No Abstract]   [Full Text] [Related]  

  • 39. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
    ; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
    Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
    Miller MA; Wenger J; Rosenstein N; Perkins B
    Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.